News

On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 ...
Autonomix Medical (Nasdaq:AMIX) announced today that it advanced its proprietary sensing catheter through a final design ...
Anxiety symptoms among U.S. adults, even during the COVID-19 pandemic, appear to have remained stable, according to a massive ...
Discover Veru Inc.'s Q3 2025 earnings insights, including Phase III enobosarm trial updates, FDA feedback, and nondilutive funding plans for ...
It is vital that clinical trials for patients with cancer shift to a more representative approach to accurately reflect ...
Research and development expenses rose 68.8% year-over-year in Q2 2025, reflecting ongoing clinical trial spending, while revenue remained at zero. Protara ended the quarter with $145.6 million in ...
Clinical trial updates in cancer care include a remote study in small cell lung cancer and new findings in ovarian, solid ...
Background Physicians are increasingly interested in part-time employment. However, the impact of part-time work on efficiency and quality of care of inpatients is unknown. Objectives To investigate ...
Objectives This study aimed to investigate the characteristics and management of influenza-like illnesses (ILIs) in the outpatient and inpatient settings in Vietnam. Design A cross-sectional, ...
Overtreatment is considered harmful in terms of decreasing quality of life, wasting resources, and environmental damage.1–3 ...
Clinical study design and research outcomes. (Bottom left) Low dose abiraterone acetate (AA) demonstrated reduced PSA levels-a marker of tumour activity. (Bottom middle) Safety profile suggested ...
This marks a turning point in Urteste’s development - the product is ready for clinical testing, the clinical study design has been aligned with the FDA, and we are launching our first clinical study ...